63323-402 : Aztreonam 2 g/1 Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 63323-402
Labeler: Fresenius Kabi USA, LLC
Product Type: Human Prescription Drug
Drug Name:  Aztreonam
Dosage Form: Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA065439
Rev. Date: 


NDC Package Codes:

  • 63323-402-20: 10 VIAL IN 1 TRAY (63323‑402‑20) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL
  • 63323-402-24: 10 VIAL IN 1 TRAY (63323‑402‑24) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL
  • 63323-402-30: 10 VIAL IN 1 TRAY (63323‑402‑30) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL

Active Ingredients:

  • Aztreonam

Dosage Strength:

  • 2 g/1

Pharmaceutical Classes:

  • Monobactam Antibacterial [EPC]
  • Monobactams [CS]

Related Products:

Based on records with the same trade name.
  • 63323-401 Aztreonam 1 g/1 Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
  • 0409-0829 Aztreonam 1 g/1 Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
  • 0409-0830 Aztreonam 2 g/1 Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 63323-402 QR Code

< Prev: 63323-401Next: 63323-403 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.